1. Stephen Buckley, Jr. Appointed to Tokai Board of Directors

    Stephen Buckley, Jr. Appointed to Tokai Board of Directors

    Tokai Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally driven diseases, today announced that Stephen Buckley, Jr...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Quotes

    1. We are delighted to welcome Steve to our board of directors.
    2. I am excited to be joining Tokai's board as galeterone is entering its Phase 3 trial in the first half of this year.
  3. Topics Mentioned